BackForesee Pharmaceuticals , Ltd. Overview

Foresee Pharmaceuticals , Ltd. Long Term Debt

Foresee Pharmaceuticals , Ltd.'s long-term debt is $380M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$384.17M
↑ 324.89% YoYΔ $293.76M vs prior year quarter

Peer trimmed avg / median

Loading

Foresee Pharmaceuticals , Ltd. Long Term Debt History

Loading

Foresee Pharmaceuticals , Ltd. vs. peers: Long Term Debt Comparison

Loading

Foresee Pharmaceuticals , Ltd. Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Foresee Pharmaceuticals , Ltd. (6576.TWO) FAQ

As of the most recent data (June 2026), 6576.TWO shows a long-term debt of $380M. That compares with $90M in the prior-year period — up 324.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6576.TWO's long-term debt is now $380M (was $90M) — a 324.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Foresee Pharmaceuticals , Ltd. is outperforming or lagging.

Tracking 6576.TWO's long-term debt over time shows whether Foresee Pharmaceuticals , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $380M That compares with $90M in the prior-year period — up 324.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Foresee Pharmaceuticals , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $380M) with ownership activity and broader fundamentals.